Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Suppression of delayed type hypersensitivity by desferoxamineD M Sahasrabudhe, J Dusel, S JedlikaThe Journal of Experimental Medicine|November 1, 1987
Inhibition of suppressor T lymphocytes by murine interferon betaD M SahasrabudheCancer Immunology, Immunotherapy : CII|December 1, 1994
Effect of murine interferon alpha/beta on tumour-induced suppressor functionD M Sahasrabudhe, J C DuselCancer|October 8, 1997
Medical oncology and geriatric medicine: is it time for fellowship integration?J M Bennett, D M Sahasrabudhe, W J HallClinical and Experimental Immunology|January 1, 1982
Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burdenJ Bray, G D MacLean, F J Dusel, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cellsC S McCune, R W O'Donnell, D M Marquis, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
Inhibition of suppressor T lymphocytes (Ts) by cimetidineD M Sahasrabudhe, C S McCune, R W O'Donnell, et al.American Journal of Hematology|September 21, 2000
CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximabJ J Ifthikharuddin, L A Mieles, J D Rosenblatt, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Shared T cell-defined antigens on independently derived tumorsD M Sahasrabudhe, D Burstyn, J C Dusel, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alphaT J Woodlock, D M Sahasrabudhe, D M Marquis, et al.Pageof 2